🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2024-519862-33-01
Ongoing Phase I

A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

2024-519862-33-01 · tracked via the Priya Life Science EU tracker
Sponsor
Oncusp Therapeutics Inc.
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
23/03/2026
Enrollment target
30
Sites
Denmark, Spain

Condition studied

Platinum-resistant ovarian cancer (PROC), Advanced renal cell carcinoma (RCC), Other advanced CDH6-positive cancers

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2024-519862-33-01 on CTIS ↗ ← All trials in the EU